Literature DB >> 2005120

Heat shock protein 90 as a critical factor in maintaining glucocorticosteroid receptor in a nonfunctional state.

F Cadepond1, G Schweizer-Groyer, I Segard-Maurel, N Jibard, S M Hollenberg, V Giguère, R M Evans, E E Baulieu.   

Abstract

Previous work demonstrated that the ligand binding domain (LBD) was required to determine the formation of the cytosolic, untransformed, inactive, 8 S, heterooligomeric form of the human glucocorticosteroid receptor (hGR) which includes the 90-kDa heat shock protein (hsp90) (Pratt, W.B., Jolly, D.J., Pratt, D.V., Hollenberg, S.M., Giguère, V., Cadepond, F.M., Schweizer-Groyer, G., Catelli, M.G., Evans, R.M., and Baulieu, E.E. (1988) J. Biol. Chem. 263, 267-273). Truncations of hGR deleting all or almost all of the LBD give GR derivatives in the non-hsp90-interacting 4 S form able to stimulate transcription in a hormone-independent manner. To identify the LBD subregion(s) involved in 8 S formation, we analyzed the sedimentation behavior of hGR mutants with various LBD internal deletions and/or truncations transiently expressed in cells that contain hsp90 but very low levels of endogenous GR, and we correlated the results with their transcriptional activity. LBD has been divided into three subregions: two of them, LBD1 (between amino acids 551 and 626) and LBD2 (between amino acids 627 and 696), include amino acid sequences highly conserved in the steroid receptor superfamily, and LBD3 consists of the carboxyl-terminal part of the molecule (amino acids 697-777). Each of these subregions can be deleted without impeding 8 S heterooligomer formation, and the corresponding receptors do not have transcriptional activity in the absence as well as in the presence of hormone. When linked to hGR mutants truncated after amino acids 532 or 550, each subregion does separately promote 8 S heterooligomeric complex formation and repress the intrinsic constitutive transcriptional activity of the truncated receptors. These 8 S complexes contain hsp90. In a control experiment, the linkage of 1,017 amino acids of beta-galactosidase to the carboxyl-terminal of 1-532 hGR gave a hybrid receptor still constitutively transcriptionally active which did not bind hsp90. These results provide evidence that there is a strong correlation between the association with hsp90 and the loss of GR functional properties and that hsp90 may play a critical role in maintaining the receptor in a nonfunctional state.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2005120

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  Aldosterone antagonists destabilize the mineralocorticosteroid receptor.

Authors:  B Couette; M Lombes; E E Baulieu; M E Rafestin-Oblin
Journal:  Biochem J       Date:  1992-03-15       Impact factor: 3.857

2.  MAPK signaling cascades mediate distinct glucocorticoid resistance mechanisms in pediatric leukemia.

Authors:  Courtney L Jones; Christy M Gearheart; Susan Fosmire; Cristina Delgado-Martin; Nikki A Evensen; Karen Bride; Angela J Waanders; Faye Pais; Jinhua Wang; Teena Bhatla; Danielle S Bitterman; Simone R de Rijk; Wallace Bourgeois; Smita Dandekar; Eugene Park; Tamara M Burleson; Pillai Pallavi Madhusoodhan; David T Teachey; Elizabeth A Raetz; Michelle L Hermiston; Markus Müschen; Mignon L Loh; Stephen P Hunger; Jinghui Zhang; Michael J Garabedian; Christopher C Porter; William L Carroll
Journal:  Blood       Date:  2015-08-31       Impact factor: 22.113

3.  Hsp90 regulates activation of interferon regulatory factor 3 and TBK-1 stabilization in Sendai virus-infected cells.

Authors:  Kai Yang; Hexin Shi; Rong Qi; Shaogang Sun; Yujie Tang; Bianhong Zhang; Chen Wang
Journal:  Mol Biol Cell       Date:  2006-01-04       Impact factor: 4.138

4.  Discrimination between NL1- and NL2-mediated nuclear localization of the glucocorticoid receptor.

Authors:  J G Savory; B Hsu; I R Laquian; W Giffin; T Reich; R J Haché; Y A Lefebvre
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

5.  A divergent role of COOH-terminal domains in Nurr1 and Nur77 transactivation.

Authors:  S O Castillo; Q Xiao; Z Kostrouch; B Dozin; V M Nikodem
Journal:  Gene Expr       Date:  1998

6.  Stimulation of transcription in vitro from a liver-specific promoter by human glucocorticoid receptor (hGRalpha).

Authors:  G Schweizer-Groyer; F Cadepond; N Jibard; E Neau; I Segard-Maurel; E E Baulieu; A Groyer
Journal:  Biochem J       Date:  1997-06-15       Impact factor: 3.857

7.  Glucocorticoid receptor localization in human epidermal cells.

Authors:  M Serres; J Viac; D Schmitt
Journal:  Arch Dermatol Res       Date:  1996-03       Impact factor: 3.017

8.  Corticosteroid use in neuro-oncology: an update.

Authors:  Patrick Roth; Caroline Happold; Michael Weller
Journal:  Neurooncol Pract       Date:  2014-10-09

9.  The molecular chaperone Hsp90 can negatively regulate the activity of a glucocorticosteroid-dependent promoter.

Authors:  K I Kang; X Meng; J Devin-Leclerc; I Bouhouche; A Chadli; F Cadepond; E E Baulieu; M G Catelli
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

10.  Dexamethasone negatively regulates the activity of a chimeric dihydrofolate reductase/glucocorticoid receptor protein.

Authors:  D I Israel; R J Kaufman
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.